HK1191329A1 - 吡唑烷- -酮衍生物 - Google Patents

吡唑烷- -酮衍生物

Info

Publication number
HK1191329A1
HK1191329A1 HK14104404.6A HK14104404A HK1191329A1 HK 1191329 A1 HK1191329 A1 HK 1191329A1 HK 14104404 A HK14104404 A HK 14104404A HK 1191329 A1 HK1191329 A1 HK 1191329A1
Authority
HK
Hong Kong
Prior art keywords
pyrazolidin
derivatives
Prior art date
Application number
HK14104404.6A
Other languages
English (en)
Inventor
喬治.耶施克
西内塞.若利多
洛塔爾.林德曼
安東尼奧.里奇
丹尼爾.吕厄
海因茨.施塔德勒
埃里克.維埃拉
Original Assignee
霍夫曼-拉羅奇有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45998366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1191329(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 霍夫曼-拉羅奇有限公司 filed Critical 霍夫曼-拉羅奇有限公司
Publication of HK1191329A1 publication Critical patent/HK1191329A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK14104404.6A 2011-04-26 2014-05-09 吡唑烷- -酮衍生物 HK1191329A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11163708 2011-04-26
PCT/EP2012/057336 WO2012146552A1 (en) 2011-04-26 2012-04-23 Pyrazolidin-3-one derivatives

Publications (1)

Publication Number Publication Date
HK1191329A1 true HK1191329A1 (zh) 2014-07-25

Family

ID=45998366

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14104404.6A HK1191329A1 (zh) 2011-04-26 2014-05-09 吡唑烷- -酮衍生物

Country Status (24)

Country Link
US (1) US8648088B2 (zh)
EP (1) EP2702050B1 (zh)
JP (1) JP5753626B2 (zh)
KR (1) KR101576343B1 (zh)
CN (1) CN103492374B (zh)
AR (1) AR086037A1 (zh)
CA (1) CA2829171C (zh)
CL (1) CL2013003068A1 (zh)
CO (1) CO6801735A2 (zh)
CR (1) CR20130476A (zh)
EA (1) EA023146B1 (zh)
EC (1) ECSP13012990A (zh)
ES (1) ES2580333T3 (zh)
HK (1) HK1191329A1 (zh)
IL (1) IL229005A (zh)
MA (1) MA35134B1 (zh)
MX (1) MX2013011107A (zh)
MY (1) MY165141A (zh)
PE (1) PE20141168A1 (zh)
SG (1) SG194095A1 (zh)
TW (1) TWI434840B (zh)
UA (1) UA113625C2 (zh)
WO (1) WO2012146552A1 (zh)
ZA (1) ZA201307404B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110862C2 (uk) * 2011-10-07 2016-02-25 Ф. Хоффманн-Ля Рош Аг Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5
UA113223C2 (xx) * 2012-08-13 2016-12-26 Арилетинілпіримідини
UA116023C2 (uk) 2013-07-08 2018-01-25 Ф. Хоффманн-Ля Рош Аг Етинільні похідні як антагоністи метаботропного глутаматного рецептора
PT3303316T (pt) 2015-06-03 2020-04-27 Hoffmann La Roche Derivados de etinilo
DK3322701T3 (da) 2015-07-15 2019-07-08 H Hoffmann La Roche Ag Ethynylderivater som metabotropiske glutamatreceptormodulatorer
AR105556A1 (es) * 2015-08-03 2017-10-18 Hoffmann La Roche Derivados de etinilo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
EP2380889B1 (en) * 2004-10-07 2013-06-26 Merck Sharp & Dohme Corp. Thiazolyl MGLUR5 antagonists and methods for their use
WO2006048771A1 (en) 2004-11-04 2006-05-11 Addex Pharmaceuticals Sa Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
GB0510139D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
EP1919890A1 (en) * 2005-08-19 2008-05-14 AstraZeneca AB Pyrazolone derivatives for the treatment of tuberculosis
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
AU2008259776A1 (en) 2007-06-03 2008-12-11 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same

Also Published As

Publication number Publication date
EA201391538A1 (ru) 2014-04-30
CO6801735A2 (es) 2013-11-29
WO2012146552A1 (en) 2012-11-01
AR086037A1 (es) 2013-11-13
CN103492374A (zh) 2014-01-01
PE20141168A1 (es) 2014-09-22
US20120277243A1 (en) 2012-11-01
KR101576343B1 (ko) 2015-12-09
TW201309669A (zh) 2013-03-01
ZA201307404B (en) 2014-06-25
TWI434840B (zh) 2014-04-21
IL229005A0 (en) 2013-12-31
NZ614883A (en) 2015-09-25
AU2012247654A1 (en) 2013-09-19
CA2829171A1 (en) 2012-11-01
US8648088B2 (en) 2014-02-11
ECSP13012990A (es) 2013-11-29
CN103492374B (zh) 2016-06-01
CA2829171C (en) 2019-02-26
CR20130476A (es) 2013-11-11
EP2702050A1 (en) 2014-03-05
SG194095A1 (en) 2013-11-29
EA023146B1 (ru) 2016-04-29
UA113625C2 (xx) 2017-02-27
JP5753626B2 (ja) 2015-07-22
MY165141A (en) 2018-02-28
KR20130143141A (ko) 2013-12-30
EP2702050B1 (en) 2016-05-18
ES2580333T3 (es) 2016-08-23
CL2013003068A1 (es) 2014-05-09
IL229005A (en) 2016-02-29
MX2013011107A (es) 2013-10-17
JP2014514315A (ja) 2014-06-19
MA35134B1 (fr) 2014-05-02

Similar Documents

Publication Publication Date Title
DK3798230T3 (en) Terapeutiske antistoffer
EP2790561A4 (en) DISHWASHER
EP2755962A4 (en) AZAINDAZOLES
EP2715659A4 (en) ABOUT FEED
EP2754063A4 (en) EXTENSIBILITY OF THE SMB2 PROTOCOL
EP2723631A4 (en) QUADFOILER
EP2776444A4 (en) dihydropteridinones
AP2014007621A0 (en) 2-Thiopyrimidinones
EP2695208A4 (en) MICRO-THERMOCOUPLE
EP2679138A4 (en) Borescope
HK1191329A1 (zh) 吡唑烷- -酮衍生物
EP2708561A4 (en) BIO-PIN
DK2770906T3 (en) Applanationstonometer
EP2684382A4 (en) EARPHONES
EP2698098A4 (en) campimeter
EP2694655A4 (en) pavec
EP2702929A4 (en) campimeter
GB201101727D0 (en) Obuoy
GB201100001D0 (en) TidySqueeze2
AU4540P (en) BUNNAN Baloskion tetraphyllum
AU5171P (en) Sunparamiho Mandevilla xamabilis
AU5031P (en) BESYS Beschorneria yuccoides
AU5026P (en) Goldstrike Agapanthus inapertus
AP00723S1 (en) Autorickshaw
AU2011303V (en) Silverado Dianella tasmanica